Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Testicular Neoplasms 1Ovarian Neoplasms 1

Interventions

Carboplatin 17Filgrastim 16Ifosfamide 13Etoposide 13Paclitaxel 11Peripheral Blood Stem Cell Transplantation 10Cisplatin 6Thiotepa 5Therapeutics 5Cyclophosphamide 5Temozolomide 4Psychiatric Rehabilitation 4Polymerase Chain Reaction 4Granulocyte Colony-Stimulating Factor 4Flow Cytometry 4Bleomycin 4Taxes 3Radiotherapy 3Methylprednisolone 3Magnetic Resonance Spectroscopy 3Amplified Fragment Length Polymorphism Analysis 3Amifostine 3sargramostim 2pegfilgrastim 2liposomal amphotericin B 2ixabepilone 2etoposide phosphate 2aldesleukin 2aflibercept 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Mesothelin × Gynecologic × Clear all
NCT05410717 2024-06-25

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Second Affiliated Hospital of Guangzhou Medical University

Phase 1 Recruiting
200 enrolled
GenitourinaryGynecologic

Ovarian Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡